Summary
The Leukemia & Lymphoma Society Inc (LLS) is a healthcare center that offers blood cancer researches and funds raising services. The center's services include patient services, health education, policy advocacy, funds raising and medical research funding. It offers treatments for the diseases such as leukemia, lymphoma, hodgkin disease and myeloma. LLS advance at the diagnosis and treatement of blood cancers by funding academic research, therapy acceleration program and other specialized initiatives. The center has its presence in the US and Canada. LLS is headquartered in White Plains, New York, the US.
The Leukemia & Lymphoma Society Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
The Leukemia & Lymphoma Society Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
The Leukemia & Lymphoma Society Inc, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
The Leukemia & Lymphoma Society Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
The Leukemia & Lymphoma Society Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
The Leukemia & Lymphoma Society Inc, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
The Leukemia & Lymphoma Society Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
OncoPep Raises USD7 Million in Series B Venture Financing 11
Partnerships 12
Kite Pharma Enters into Agreement with Leukemia & Lymphoma Society 12
Evotec Enters Into Research Agreement With Leukemia & Lymphoma Society 13
Stemline Therapeutics Enters Into Co-Development Agreement With Leukemia & Lymphoma Society 14
Constellation Pharma Enters Into Agreement With Leukemia & Lymphoma Society To Develop BET Inhibitors Drugs For Hematologic Cancers 16
The Leukemia & Lymphoma Society Enters Into Co-Development Agreement With Celator Pharma For CPX-351 18
Curis Enters Into Co-Development Agreement With The Leukemia & Lymphoma Society 19
Leukemia & Lymphoma Society Enters Into An Agreement With EpiZyme 21
Acetylon Pharma Enters Into Co-Development Agreement With Leukemia & Lymphoma Society 23
Ascenta Therapeutics Enters Into Co-Development Agreement With The Leukemia & Lymphoma Society 25
The Leukemia & Lymphoma Society Enters Into An Agreement With BioTheryX 26
The Leukemia & Lymphoma Society Enters Into An Agreement With Shape Pharma 27
Avila Therapeutics Enters Into Co-Development Agreement With The Leukemia & Lymphoma Society 28
Leukemia & Lymphoma Enters Into Drug Discovery Agreement With FORMA Therapeutics 29
Equity Offering 30
Kiadis Pharma Raises USD0.8 Million in Second Tranche of Private Placement of Shares 30
Kiadis Pharma Raises USD1 Million in Private Placement of Shares 32
The Leukemia & Lymphoma Society Inc - Key Competitors 34
Key Employees 35
Locations And Subsidiaries 36
Head Office 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37
List of Tables
The Leukemia & Lymphoma Society Inc, Pharmaceuticals & Healthcare, Key Facts 1
The Leukemia & Lymphoma Society Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
The Leukemia & Lymphoma Society Inc, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
The Leukemia & Lymphoma Society Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
The Leukemia & Lymphoma Society Inc, Deals By Therapy Area, 2010 to YTD 2016 8
The Leukemia & Lymphoma Society Inc, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
OncoPep Raises USD7 Million in Series B Venture Financing 11
Kite Pharma Enters into Agreement with Leukemia & Lymphoma Society 12
Evotec Enters Into Research Agreement With Leukemia & Lymphoma Society 13
Stemline Therapeutics Enters Into Co-Development Agreement With Leukemia & Lymphoma Society 14
Constellation Pharma Enters Into Agreement With Leukemia & Lymphoma Society To Develop BET Inhibitors Drugs For Hematologic Cancers 16
The Leukemia & Lymphoma Society Enters Into Co-Development Agreement With Celator Pharma For CPX-351 18
Curis Enters Into Co-Development Agreement With The Leukemia & Lymphoma Society 19
Leukemia & Lymphoma Society Enters Into An Agreement With EpiZyme 21
Acetylon Pharma Enters Into Co-Development Agreement With Leukemia & Lymphoma Society 23
Ascenta Therapeutics Enters Into Co-Development Agreement With The Leukemia & Lymphoma Society 25
The Leukemia & Lymphoma Society Enters Into An Agreement With BioTheryX 26
The Leukemia & Lymphoma Society Enters Into An Agreement With Shape Pharma 27
Avila Therapeutics Enters Into Co-Development Agreement With The Leukemia & Lymphoma Society 28
Leukemia & Lymphoma Enters Into Drug Discovery Agreement With FORMA Therapeutics 29
Kiadis Pharma Raises USD0.8 Million in Second Tranche of Private Placement of Shares 30
Kiadis Pharma Raises USD1 Million in Private Placement of Shares 32
The Leukemia & Lymphoma Society Inc, Key Competitors 34
The Leukemia & Lymphoma Society Inc, Key Employees 35
List of Figures
The Leukemia & Lymphoma Society Inc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
The Leukemia & Lymphoma Society Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
The Leukemia & Lymphoma Society Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
The Leukemia & Lymphoma Society Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
The Leukemia & Lymphoma Society Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
The Leukemia & Lymphoma Society Inc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
The Leukemia & Lymphoma Society Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
The Leukemia & Lymphoma Society Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
